Current Grants

To date, the Foundation has awarded over $12 million for MPN research. Awards follow an extensive proposal review process conducted by the MPN Foundation’s Scientific Advisory Board as well as additional MPN experts who gave generously of their time and expertise. Click here for a complete list of current and past grants made by the Foundation. Click here for descriptions of our past research programs. 

Our Current Active Grants

  • The MPN Challenge grant program is our biannual open RFP research initiative which allows us to fund the most pressing MPN science. The focus areas change each year as we learn more about unmet need in MPN research. In the past we've focused on CRISPR, selective JAK2 inhibition, inflammation, Interferon and more. Researchers are given 2 year grants with regular progress reports to ensure they are making headway. Read about 2017's grantees here.
     
  • MPN Interferon Initiative seeks to answer the intractable questions of why Interferon works for some patients, even reducing allele burden, but is not tolerated or ineffective in others. The MPNRF Interferon (IFN) Initiative is a multi-center project which has brought together internationally recognized experts in both blood and solid tumors to answer these questions, which could have wide-ranging impact on the lives of people living with cancer. Read more about this project here
     
  • The NUTRIENT Study came about after learning about a hypothesis related to inflammation, diet and allele burden in MPN. This grant will provide the young investigator with the data needed to apply for a larger grant, as we did with Ron Hoffman's 2006 support for the MPD Research Consortium, which has now received $65 million in funding from the NIH. Read more about this project here (bottom of page). 

Subscribe to updates to learn more about available MPN treatments.

Antonio

Myelofibrosis (MF)

Meet Antonio

Take the steps you need to help change your prognosis.

x

NEVER MISS AN UPDATE

Get free, timely information on living with an MPN.

Subscribe